• The document is an intimation of a scheduled Analyst/Investor Meeting, filed as a regulatory compliance disclosure with BSE Limited and National Stock Exchange of India Limited.
  • The event is a One to One meeting specifically with East Bridge Capital.
  • The meeting is scheduled for Tuesday, August 25, 2026, from 07:00 P.M. to 08:00 P.M. (Indian Standard Time, implied by +05:30 timestamp).
  • The mode of the meeting is Virtual.
  • The stated purpose is a meeting with Analyst(s)/Institutional Investor(s), though no specific discussion topics (e.g., results, strategy) are detailed.
  • A presentation for the meeting will be made available and accessible via the provided link: https://d28c6jni2fmamz.cloudfront.net/8ECPQ1FY27_8dec5fbe94.pdf.
  • The disclosure will also be available on the Company's website at www.starhealth.in.
  • The document includes a note that the meeting is subject to changes that may happen due to exigencies on the part of Analysts/Investors of the Company.
  • No management participants or their designations are listed in the disclosure.
  • The document does not contain any explicit statement regarding the sharing of Unpublished Price Sensitive Information (UPSI).
  • No financial highlights, guidance references, or presentation summaries are included in this specific intimation document.

Additional Notes Section

  • This is a standalone regulatory intimation letter (Ref: SHAI/B & S/SE/81/2026-27) and does not list any attachments, such as a presentation deck or invite.
  • No financial data or performance figures were disclosed in this announcement.
  • The document is digitally signed by Jayashree Sethuraman, Company Secretary & Compliance Officer, on August 13, 2026.